+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Cold Chain Logistics: Global Strategic Business Report

  • PDF Icon

    Report

  • 274 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140964

Global Healthcare Cold Chain Logistics Market to Reach $20.9 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Healthcare Cold Chain Logistics estimated at US$16.5 Billion in the year 2020, is projected to reach a revised size of US$20.9 Billion by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027. Vaccines, one of the segments analyzed in the report, is projected to record a 3.1% CAGR and reach US$9.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Clinical Trial Materials segment is readjusted to a revised 3.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 5.5% CAGR

The Healthcare Cold Chain Logistics market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2027 trailing a CAGR of 5.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.7 Billion by the year 2027.

Biopharmaceuticals Segment to Record 3.9% CAGR

In the global Biopharmaceuticals segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$3.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 4.2% CAGR through the analysis period.

Select Competitors (Total 44 Featured) -

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and a Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Healthcare Cold Chain Logistics

What is the estimated value of the Global Market for Healthcare Cold Chain Logistics?

The Global Market for Healthcare Cold Chain Logistics was estimated to be valued at $16.5 Billion in 2020.

What is the growth rate of the Global Market for Healthcare Cold Chain Logistics?

The growth rate of the Global Market for Healthcare Cold Chain Logistics is 3.4%, with an estimated value of $20.9 Billion by 2027.

What is the forecasted size of the Global Market for Healthcare Cold Chain Logistics?

The Global Market for Healthcare Cold Chain Logistics is estimated to be worth $20.9 Billion by 2027.

Who are the key companies in the Global Market for Healthcare Cold Chain Logistics?

Key companies in the Global Market for Healthcare Cold Chain Logistics include American Airlines, Inc., AmerisourceBergen Corporation, Cavalier Logistics, Continental Carbon Company, DB Schenker, DHL International GmbH, FedEx Corporation and Marken Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Healthcare Cold Chain Logistics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Healthcare Cold Chain Logistics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
  • Table 2: World Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 3: World 15-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World 15-Year Perspective for Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 6: World Recent Past, Current & Future Analysis for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 7: World 15-Year Perspective for Clinical Trial Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 8: World Recent Past, Current & Future Analysis for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 9: World 15-Year Perspective for Biopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World 15-Year Perspective for Transportation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 12: World Recent Past, Current & Future Analysis for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 13: World 15-Year Perspective for Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 14: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 15: World 15-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Historic Review for Healthcare Cold Chain Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 17: World Historic Review for Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World Historic Review for Clinical Trial Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 19: World Historic Review for Biopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 20: World Historic Review for Transportation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World Historic Review for Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 22: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
III. MARKET ANALYSIS
UNITED STATES
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 25: USA Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 27: USA Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 28: USA Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 31: Canada Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 33: Canada Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 34: Canada Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
JAPAN
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 37: Japan Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 39: Japan Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 40: Japan Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CHINA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: China 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 43: China Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: China 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 45: China Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 46: China Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
EUROPE
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 48: Europe 15-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
  • Table 49: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 51: Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 53: Europe Historic Review for Healthcare Cold Chain Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 54: Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 55: Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
FRANCE
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 57: France 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 58: France Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 59: France 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 60: France Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 61: France Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
GERMANY
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 63: Germany 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 64: Germany Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 65: Germany 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 66: Germany Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 67: Germany Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 69: Italy 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 70: Italy Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 71: Italy 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 72: Italy Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 73: Italy Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 75: UK 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 76: UK Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 77: UK 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 78: UK Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 79: UK Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 81: Spain 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 82: Spain Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 83: Spain 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 84: Spain Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 85: Spain Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 87: Russia 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 88: Russia Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 89: Russia 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 90: Russia Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 91: Russia Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 93: Rest of Europe 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 94: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 95: Rest of Europe 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 96: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 97: Rest of Europe Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 99: Asia-Pacific 15-Year Perspective for Healthcare Cold Chain Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
  • Table 100: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 101: Asia-Pacific 15-Year Perspective for Healthcare Cold Chain Logistics by Product Type - Percentage Breakdown of Value Sales for Vaccines, Clinical Trial Materials and Biopharmaceuticals for the Years 2012, 2021 & 2027
  • Table 102: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 103: Asia-Pacific 15-Year Perspective for Healthcare Cold Chain Logistics by Segment - Percentage Breakdown of Value Sales for Transportation, Packaging and Instrumentation for the Years 2012, 2021 & 2027
  • Table 104: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Product Type - Vaccines, Clinical Trial Materials and Biopharmaceuticals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 106: Asia-Pacific Historic Review for Healthcare Cold Chain Logistics by Segment - Transportation, Packaging and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
AUSTRALIA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Healthcare Cold Chain Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • American Airlines, Inc.
  • AmerisourceBergen Corporation
  • Cavalier Logistics
  • Continental Carbon Company
  • DB Schenker
  • DHL International GmbH
  • FedEx Corporation
  • Kuehne + Nagel International AG
  • Marken Ltd.